FDA clearances and approvals, off-label use, scope-of-practice rules, and how to read a 510(k) summary without trusting the marketing wrapper.
Emface pairs synchronized radiofrequency with HIFES facial-muscle stimulation. We break down what the FDA cleared it for, what the small manufacturer studies show, and…
Semaglutide's key US patent runs to late 2031 and tirzepatide's to early 2036. We read the FDA Orange Book to show when generic GLP-1 weight-loss drugs can actually…
The FDA's proposed exclusion of semaglutide and tirzepatide from the 503B Bulks List will end industrial GLP-1 compounding in 2026. A guide to legal timelines and…
Cosmetic Botox is excluded from HSA/FSA funds, but therapeutic Botox for migraine, hyperhidrosis, or TMJ qualifies with an LMN and proper coding. A detailed regulatory…
Plasma pens bypass FDA cosmetic reviews, but voluntary MAUDE databases reveal severe risks of atrophic scarring and hypopigmentation requiring costly laser corrections.
Chin implant (FWP) FDA MAUDE analysis: across 237 reports patient injury dominates and infection is the leading complication theme — with the caveats MAUDE demands.
FDA warnings on needle-free dermal filler devices (Hyaluron Pens). High-pressure jet injection carries severe risks of skin necrosis, permanent blindness, and clinical…
A comprehensive guide to California's strict laser hair removal regulations: medical board scope-of-practice rules, eligible providers, esthetician prohibitions, and…
How aesthetic devices clear the SFDA — Class A–D classification, the GHAD portal and MDMA pathway, the Local Authorized Representative requirement, and Saudi market…
A comprehensive guide to Florida laser hair removal licensing in 2026. Learn about the Electrolysis Council, Rule 64B8-56.002, and supervision rules.